Nifty above 23,000 level; media shares advance

Image
Last Updated : Jan 29 2025 | 10:53 AM IST
At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 403.09 points or 0.53% to 76,310.97. The Nifty 50 index added 131.10 points or 0.57% to 23,088.35.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 1.96% and the S&P BSE Small-Cap index rallied 2.41%.

The market breadth was strong. On the BSE, 2,796 shares rose and 764 shares fell. A total of 161 shares were unchanged.

Result Today:

Maruti Suzuki India(up 0.97%), Tata Motors(up 1.79%), Bajaj Finance(up 1.23%), Adani Power(up 1.02%), Ambuja Cements(up 0.42%), ACME Solar Holdings(up 9.99%), ASK Automotive(up 3.89%), Blue Dart Express(up 1.33%), Blue Star(up 3.38%), Brigade Enterprises(up 2.94%), Computer Age Management Services(up 1.49%), CarTrade Tech(up 7.61%), Chalet Hotels(up 3.40%), Deepak Fertilisers(up 5.83%), Indian Bank(up 2.21%), Jindal Stainless(up 1.89%), Hitachi Energy India(up 8.04%), Raymond(up 2.75%), Voltas(up 2.44%), and Allied Blenders and Distillers(up 3.90%) will declare their quarterly earnings later today.

Buzzing Index:

The Nifty Media index advanced 2.29% to 1,581.60. The index slipped 6.26% in three consecutive trading sessions.

Network 18 Media & Investments (up 4.69%), Nazara Technologies (up 4.59%), Dish TV India (up 4.02%), Saregama India (up 3.15%), Tips Music (up 2.43%), Sun TV Network (up 2.16%), Hathway Cable & Datacom (up 2.1%), PVR Inox (up 1.58%), and Zee Entertainment Enterprises (up 0.96%) advanced.

Stocks in Spotlight:

Colgate-Palmolive (India) fell 1.61% after the company reported net profit declined 2.22% to Rs 322.78 crore in Q3 FY25 as against Rs 330.11 crore posted in Q3 FY24. Revenue from operations grew by 4.74% year on year (YoY) to Rs 1,452.21 crore in the quarter ended 31 December 2024.

VA TECH WABAG jumped 5.98% after the company said that it has secured an operation contract worth $14 million (approximately Rs 121 crore) from BAPCO Refining B.S.C (BAPCO).

OneSource Specialty Pharma added 1.20%. The company has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its BLD facility in Bangalore. The inspection of the facility was conducted from 14-22 November 2024.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 29 2025 | 10:35 AM IST

Next Story